# Botulinum Toxin-A for Bruxism Using Digital Occlusal Analysis

> **NCT07640035** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Bilecik Seyh Edebali Universitesi** · enrollment: 36 (estimated)

## Conditions studied

- Bruxism

## Interventions

- **DRUG:** Botulinum Toxin-A injection
- **DRUG:** Placebo (saline injection)

## Key facts

- **NCT ID:** NCT07640035
- **Lead sponsor:** Bilecik Seyh Edebali Universitesi
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-20
- **Primary completion:** 2026-12-20
- **Final completion:** 2027-07-20
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640035, "Botulinum Toxin-A for Bruxism Using Digital Occlusal Analysis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*